全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

葛根芩连结肠定位片的制备工艺研究
Study on the Preparation Technology of Gegen Qinlian Colon Localization Tablet

DOI: 10.12677/tcm.2024.138277, PP. 1853-1870

Keywords: 葛根芩连汤,溃疡性结肠炎,结肠定位片,压片工艺,包衣工艺
Gegen Qinlian Decoction
, Ulcerative Colitis, Colonic Positioning Tablet, Compression Process, Coating Process

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:优选葛根芩连结肠定位片的最佳制备工艺。方法:根据pH和时间依赖型双重释药原理,优选葛根芩连结肠定位包衣片的最佳压片工艺和包衣工艺,通过粉末直接压片法制备定位片芯,薄膜多层包衣制备葛根芩连结肠定位片;单因素法考察包衣处方的影响因素,再采用Box-Behnken响应面法对处方进一步优化,以筛选出最佳的处方范围,并按照优化的制剂处方和制备工艺,制备结肠定位片和普通片并进行体外释放度实验研究。结果:片芯处方工艺为以浸膏粉40%,微晶纤维素26.75%,乳糖26.75%,羧甲基淀粉钠6%,硬脂酸镁0.5%进行粉末直接压片;包衣处方为从内到外依次包时滞层、肠溶层,包衣增重分别为1.0%、4.44%。时滞层处方为Eudragit RL:RS (1:2) 10 g,邻苯二甲酸二乙酯1 g,滑石粉5 g,95%乙醇200 mL;肠溶层处方为Eudragit L:S (1:5) 10 g,柠檬酸三乙酯2 g,滑石粉5 g,95%乙醇200 mL。包衣片在人工胃液中2小时内无药物释放,在人工小肠液中4小时内无药物释放,在人工结肠液中大量释放,8小时内药物累积释药百分率达到标示量的90%以上,达到结肠定位制剂释药要求。结论:该方法稳定可行,可用于葛根芩连结肠定位片的成型工艺研究。
Objective: To optimize the preparation technology of Gegen Qinlian colon positioning tablets. Methods: According to the pH and time dependent double drug release principle, the optimal compression and coating technology of Gegen Qinlian colon positioning coating tablets were optimized, and the positioning core was prepared by direct powder compression method, and the Gegen Qinlian colon positioning tablets were prepared by multilayer film coating. Single factor method was used to investigate the influencing factors of coating prescription, and Box-Behnken response surface method was used to further optimize the prescription to screen out the best prescription range. According to the optimized formulation and preparation technology, colon positioning tablets and ordinary tablets were prepared and the release degree of in vitro experiment was conducted. Results: The tablet core formulation consisted of 40% extractum powder, 26.75% microcrystalline cellulose, 26.75% lactose, 6% sodium carboxymethyl starch and 0.5% magnesium stearate. The coating prescription was coated with delay layer and enteric layer from inside to outside, the coating weight gain was 1.0% and 4.44%, respectively. The coating prescription was Eudragit RL:RS (1:2) 10 g, diethyl phthalate 1 g, talc powder 5 g, 95% ethanol 200 mL. The enteric layer prescription was Eudragit L:S (1:5) 10 g, triethyl citrate 2 g, talc powder 5 g, 95% ethanol 200 mL. There was no drug release in the artificial gastric juice within 2 hours, no drug release in the artificial small intestine fluid within 4 hours, and a large amount of drug release in the artificial colon fluid, and the cumulative drug release percentage reached more than 90% of the labeled amount within 8 hours, to meet the requirements of colonic localization drug release. Conclusion: The method is

References

[1]  Wang, T., Liu, X., Zhang, W., Wang, J., Wang, T., Yue, W., et al. (2024) Traditional Chinese Medicine Treats Ulcerative Colitis by Regulating Gut Microbiota, Signaling Pathway and Cytokine: Future Novel Method Option for Pharmacotherapy. Heliyon, 10, e27530.
https://doi.org/10.1016/j.heliyon.2024.e27530
[2]  Zeng, Z., Ouyang, J., Sun, L., Zeng, F. and Wu, S. (2022) A Biomarker‐Responsive Nanosystem with Colon‐targeted Delivery for Ulcerative Colitis’s Detection and Treatment with Optoacoustic/NIR‐II Fluorescence Imaging. Advanced Healthcare Materials, 11, Article ID: 2201544.
https://doi.org/10.1002/adhm.202201544
[3]  周策, 易泽林, 张明星, 等. 干姜黄芩黄连人参汤通过NLRP3/caspase-1途径对溃疡性结肠炎小鼠结肠上皮细胞焦亡的影响[J/OL]. 中成药: 1-7.
http://kns.cnki.net/kcms/detail/31.1368.R.20240628.1524.002.html, 2024-07-01.
[4]  Wang, N., Wu, T., Du, D., Mei, J., Luo, H., Liu, Z., et al. (2022) Transcriptome and Gut Microbiota Profiling Revealed the Protective Effect of Tibetan Tea on Ulcerative Colitis in Mice. Frontiers in Microbiology, 12, Article 7485494.
https://doi.org/10.3389/fmicb.2021.748594
[5]  路立峰, 张媛媛, 李振兴, 等. 葛根芩连汤药效物质基础及质量控制研究进展[J]. 中成药, 2022, 44(10): 3239-3243.
[6]  Lin, C., Zhou, Z., Zhang, L., Wang, H., Lu, J., Wang, X., et al. (2022) Gegen Qinlian Decoction Relieves Ulcerative Colitis via Adjusting Dysregulated Nrf2/ARE Signaling. Evidence-Based Complementary and Alternative Medicine, 2022, Article ID: 2934552.
https://doi.org/10.1155/2022/2934552
[7]  郑晨曦, 冯嘉轩, 陈昭彤, 等. 葛根芩连汤对溃疡性结肠炎小鼠肠道屏障的保护作用机制研究[J]. 中国兽医学报, 2023, 43(3): 1-7.
[8]  Liu, X., Fan, Y., Du, L., Mei, Z. and Fu, Y. (2021) In Silico and in Vivo Studies on the Mechanisms of Chinese Medicine Formula (Gegen Qinlian Decoction) in the Treatment of Ulcerative Colitis. Frontiers in Pharmacology, 12, Article 665102.
https://doi.org/10.3389/fphar.2021.665102
[9]  张玉洁, 刘兴山. 溃疡性结肠炎的发病机制及中医药干预进展[J]. 实用中医内科杂志, 2024, 38(6): 136-138.
[10]  周春雨, 代月优, 王白燕, 等. 葛根芩连汤治疗溃疡性结肠炎研究进展[J]. 辽宁中医药大学学报, 2024, 26(4): 179-184.
[11]  Li, Q., Cui, Y., Xu, B., Wang, Y., Lv, F., Li, Z., et al. (2021) Main Active Components of Jiawei Gegen Qinlian Decoction Protects against Ulcerative Colitis under Different Dietary Environments in a Gut Microbiota-Dependent Manner. Pharmacological Research, 170, Article ID: 105694.
https://doi.org/10.1016/j.phrs.2021.105694
[12]  Ma, J., Zhang, J., Wang, Y., Huang, J., Yang, X., Ma, J., et al. (2023) Modified Gegen Qinlian Decoction Ameliorates Dss-Induced Chronic Colitis in Mice by Restoring the Intestinal Mucus Barrier and Inhibiting the Activation of γδT17 Cells. Phytomedicine, 111, Article ID: 154660.
https://doi.org/10.1016/j.phymed.2023.154660
[13]  王秀敏, 赵朕雄, 夏哲林. 中药口服结肠靶向给药系统在溃疡性结肠炎防治中的研究进展[J]. 中成药, 2024, 46(6): 1929-1934.
[14]  Tang, X., Zhang, X. and Zhao, Q. (2022) A pH/Time/Pectinase-Dependent Oral Colon-Targeted System Containing Isoliquiritigenin: Pharmacokinetics and Colon Targeting Evaluation in Mice. European Journal of Drug Metabolism and Pharmacokinetics, 47, 677-686.
https://doi.org/10.1007/s13318-022-00783-8
[15]  Wang, Q., Wang, G., Zhou, J., Gao, L. and Cui, Y. (2016) Colon Targeted Oral Drug Delivery System Based on Alginate-Chitosan Microspheres Loaded with Icariin in the Treatment of Ulcerative Colitis. International Journal of Pharmaceutics, 515, 176-185.
https://doi.org/10.1016/j.ijpharm.2016.10.002
[16]  Shahdadi Sardo, H., Saremnejad, F., Bagheri, S., Akhgari, A., Afrasiabi Garekani, H. and Sadeghi, F. (2019) A Review on 5-Aminosalicylic Acid Colon-Targeted Oral Drug Delivery Systems. International Journal of Pharmaceutics, 558, 367-379.
https://doi.org/10.1016/j.ijpharm.2019.01.022
[17]  Sarangi, M.K., Rao, M.E.B. and Parcha, V. (2020) Smart Polymers for Colon Targeted Drug Delivery Systems: A Review. International Journal of Polymeric Materials and Polymeric Biomaterials, 70, 1130-1166.
https://doi.org/10.1080/00914037.2020.1785455
[18]  胡英男, 唐静仪, 祝维涵, 等. 葛根芩连汤调控细胞因子治疗溃疡性结肠炎作用机制研究进展[J/OL]. 中华中医药学刊, 1-9.
http://kns.cnki.net/kcms/detail/21.1546.R.20240611.1537.004.html, 2024-07-01.
[19]  王钰乐, 刘文, 杨道斌, 等. 葛根芩连汤的UPLC-MS/MS指纹图谱研究[J]. 中药新药与临床药理, 2017, 28(2): 206-211.
[20]  刘文, 王钰乐, 卿勇军, 等. 葛根芩连汤治疗溃疡性结肠炎谱效关系研究[J]. 中华中医药杂志, 2018, 33(9): 4093-4097.
[21]  王钰乐. 葛根芩连汤指纹图谱、药效学及谱效关系初步研究[D]: [硕士学位论文]. 贵阳: 贵阳中医学院, 2017.
[22]  Wang, Y., Liu, W., Yang, D., Qing, Y., Du, P., Jin, Y., et al. (2017) Establishment of Fingerprint of Gegen Qinlian Decoction and Its Formula Compatibility Groups Using UHPLC-MS/MS and Its Study to Spectrum-Effect Relationship. Journal of Liquid Chromatography & Related Technologies, 41, 384-390.
https://doi.org/10.1080/10826076.2017.1386674
[23]  何雯, 朱华, 卜平. 中药口服结肠定位给药系统研究进展[J]. 时珍国医国药, 2016, 27(10): 2484-2485.
[24]  刘志强. 新疆一枝蒿结肠靶向定位片的研制[D]: [硕士学位论文]. 南昌: 江西中医药大学, 2023.
[25]  陈岩勤, 黄家宇, 陆家堂, 等. 姜黄素结肠定位片的制备及其体外释放评价[J]. 时珍国医国药, 2020, 31(7): 1623-1625.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133